AI Terminal
HEMOGENYX PHARMACEUTICALS PLC
Director's Dealing • Sep 22, 2020
4938_dirs_2020-09-22_d57dfd17-8684-4a46-af79-5fe8a7025935.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 7514Z
Hemogenyx Pharmaceuticals PLC
22 September 2020
22 September 2020
Hemogenyx Pharmaceuticals plc
("Hemogenyx Pharmaceuticals" or the "Company")
Further re. Grant of Options
On 21 August 2020, the Company announced that the Directors had granted the Company's co-founder and CEO Dr Vladislav Sandler options over a total of 5,000,000 ordinary shares of 1p each in the capital of the Company ("Share Options"). The Directors have now resolved to adjust the exercise price of the Share Options to 9p to reflect the Company's share price at the time of the grant. All other details regarding the grant of the Share Options remain the same.
Enquiries:
| Hemogenyx Pharmaceuticals plc | https://hemogenyx.com |
| Dr Vladislav Sandler, Chief Executive Officer & Co-Founder | [email protected] |
| Peter Redmond, Director | [email protected] |
| SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 |
| Matthew Johnson, Vadim Alexandre, Soltan Tagiev | |
| Peterhouse Capital Limited | Tel: +44 (0)20 7469 0930 |
| Lucy Williams, Duncan Vasey, Charles Goodfellow |
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them ("PCA"):
1.
Details of PDMR/person closely associated with them
a)
Name
Dr Vladislav Sandler
b)
Position/status
CEO, Executive Director
c)
Initial notification/
amendment
Amendment to prior notification no. 00117904
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Options over ordinary shares of 1p of Hemogenyx Pharmaceuticals plc
Identification code GB00BYX3WZ24
b)
Nature of the transaction
Grant of options
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.09 | 5,000,000 |
d)
Aggregated information
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| N/A - variable | 5,000,000 |
e)
Date of the transaction
20/08/2020
f)
Place of the transaction
Outside of a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHPPUBCBUPUGGP